IEX · 10-Q · 2026Q3 · Full report

Revenue Performance and Mix

IDEX CORP /DE/ · 2026-10-28 · Importance 43 · Surprise 32 · Contradicted

Third-quarter 2026 net sales increased 8% to $951.7 million from $878.7 million, while nine-month sales rose 8% to $2,759.2 million from $2,558.4 million. Organic sales grew 8% in the quarter and 6% in the nine-month period, driven by higher volumes, primarily in HST, and positive pricing across all segments. Nine-month sales also benefited from foreign-currency translation and acquisitions; international sales increased $58.7 million in the quarter and $117.5 million over nine months, compared with domestic increases of $14.3 million and $83.3 million, respectively.

Key facts

• For the three months ended September 30, 2026, net sales were $951.7 million, up 8% on both a reported and organic basis. source
• For the three and nine months ended September 30, 2026, organic sales increased 8% and 6%, respectively, driven by higher volumes primarily in HST; both periods also reflected positive price across all segments. source
• For the three and nine months ended September 30, 2026, domestic sales were $473.5 million and $1,397.7 million, respectively, and international sales were $478.2 million and $1,361.5 million, respectively. source
• For the three and nine months ended September 30, 2026, net sales were $951.7 million and $2,759.2 million, respectively. source
• For the three months ended September 30, 2026, reported diluted EPS attributable to IDEX was $1.95, an increase of 15%. source
• For the three months ended September 30, 2026, adjusted diluted EPS attributable to IDEX was $2.33, an increase of 15%. source

Impact estimates